Leukaemia UK is a member of the Blood Cancer Alliance, a group of fifteen UK charities. Together, we are working to tackle the issues blood cancer patients face. As well as improving the experience and outcomes of all those living with blood cancer.

Leukaemia UK is part of Cancer52. This is a national policy and campaigning charity of over 100 small charities, that represent the less common and rarer cancers. Although less common, these account for more than half of all cancer deaths in the UK. Its aim is to promote improved diagnosis, treatment and support for those affected by rare and less common cancers.

Leukaemia UK is a member of the Association of Medical Research Charities (AMRC), the UK membership organisation of leading medical and health research charities. Membership of the AMRC is an endorsement of the quality of our research funding. Our membership gives reassurance to donors that all funding requests are subject to a stringent and transparent review process. And that we only support the very best projects.

We work in partnership with the Medical Research Council. Together we fund two clinical research training fellowships per year. These fellowships offer clinical professionals the opportunity to launch novel research projects that combine two fields of expertise: clinical care and biological research.

There is an urgent need to improve leukaemia survival rates following stem cell transplants. So Leukaemia UK and other partners developed the IMPACT (the Partnership for Accelerated Clinical Trials) initiative. The aim of the initiative is to provide a national platform for the development, approval and delivery of a portfolio of clinical trials in the field of stem cell transplantation.

The National Institute for Health Research are our non-commercial partners for the IMPACT initiative. They fund, enable and deliver world-leading health and social care research that improves people’s health and wellbeing, and promotes economic growth.

We collaborate with Leukaemia Care for the Spot Leukaemia campaign. Together, we’re working to raise awareness of the signs and symptoms of leukaemia. As well as help more people recognise these and get diagnosed earlier.

Along with 125 organisations, we have signed the Concordat on Openness on Animal Research. This is a set of commitments for UK-based life science organisations to enhance their animal research communications.

We are a part of One Cancer Voice, a coalition of 51 cancer charities. We communicate the need to develop world-leading cancer services to the Government and the NHS, as we find a route out of the pandemic

Anthony Nolan is the world’s first stem cell register. They are joint funding partners for the IMPACT stem cell transplant clinical trials initiative, along with Leukaemia UK and NHS Blood and Transplant. 

NHS Blood and Transplant are joint funding partners for the IMPACT stem cell transplant clinical trials initiative, along with Leukaemia UK and Anthony Nolan. They provide a blood and transplantation service to the NHS, looking after blood donation services in England and transplant services across the UK.